Rhythm Pharmaceuticals, Inc. RYTM Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

Aardvark Therapeutics, Inc.AARD

-58.8%—

Viking TherapeuticsVKTX

-70%-94.5pp

Mirum Pharmaceuticals, Inc.MIRM

-335.8%-377pp

TG TherapeuticsTGTX

100.3%+73.6pp

Neurocrine BiosciencesNBIX

22.5%+10.1pp

FAQ

What is Rhythm Pharmaceuticals, Inc.'s return on equity?

Rhythm Pharmaceuticals, Inc. (RYTM) reported return on equity of -285.8% in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s return on equity changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s return on equity increased by 31.8% year-over-year, from -419% to -285.8%.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s return on equity?

Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s return on equity has grown at a 32.5% compound annual growth rate (CAGR), from -59.9% to -244.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.